Mitsubishi Tanabe Pharma Corp.

Pharmaceuticals
Japan
Executive 1Michihiro Tsuchiya, Chairman; | Chairman;
Executive 2Masayuki Mitsuka, President; | Chief Executive Officer; Executive Director
Earnings Per Share Growth (%)N/A
Cost of Goods Sold (US$ Millions)$1,421
Current Liabilities (US$ Millions)$1,080
Total Assets (US$ Millions)$5,059
Long Term Debt (Millions)$7
Return on Equity5.15%
Revenue (US$ Millions)$3,479
Total Company Assets$7,789
Revenue Growth (%)0.59%
Net Income (US$ Millions)$331
Earnings Per Share (US$)N/A
Total Equity (US$ Millions)$6,504
Profit Margin (%)9.52%
Debt To Equity Ratio (%)0.00%
Inventories (Millions)$713